Stocks · Healthcare · Medical - Care Facilities
Option Care Health, Inc. OPCH
$22.64 +0.27% Close, Oct 2, 2026 · NASDAQ · Market cap $3.39B
Inexpensive vs sectorLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The shares trade at 17.0× trailing earnings, lower than 95% of the company's own readings over the past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- The diluted share count fell 5.1% in a year, mainly through buybacks.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 42%
- EPS growth (TTM, YoY)Bottom 47%
- FCF growth (TTM, YoY)Top 31%
- Revenue growth, 3-year CAGRTop 44%
- Revenue growth accelerationBottom 30%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 15%
- Gross marginBottom 14%
- Operating marginTop 33%
- Cash conversion (OCF / net income)Top 45%
- Accruals (lower is better)Bottom 36%
- Net debt / EBITDA (lower is better)Bottom 35%
- Interest coverTop 24%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 7%
- Free-cash-flow yieldTop 7%
- EBITDA / enterprise valueTop 11%
- Sales / enterprise valueTop 6%
- P/E vs own 5-year history (lower is better)Top 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 28%
- 6-month returnBottom 26%
- 1-year return vs S&P 500Bottom 31%
- Distance from 52-week highBottom 42%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 48%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 44%
- Upside to consensus price targetBottom 31%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 10%
- Maximum drawdown, 3 yearsTop 20%
- Beta vs S&P 500 (lower is better)Top 15%
- Net debt / EBITDA (lower is better)Bottom 35%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.3% | 5.9% | ↓ |
| EPS growth (YoY) | 4.0% | 6.4% | ↑ |
| Gross margin | 19.1% | 18.2% | ↓ |
| Operating margin | 6.2% | 5.9% | ↓ |
| FCF margin | 4.5% | 6.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 5.9% | 9.3% | ↓ | Bottom 42% |
| EPS growth (TTM, YoY) | 6.4% | 4.0% | ↑ | Bottom 47% |
| Gross margin | 18.2% | 19.1% | ↓ | Bottom 14% |
| Operating margin | 5.9% | 6.2% | ↓ | Top 33% |
| Net margin | 3.7% | 3.9% | ↓ | — |
| Free-cash-flow margin | 6.1% | 4.5% | ↑ | — |
| Return on invested capital | 9.6% | — | Top 15% | |
| Revenue growth, 3-year CAGR | 12.7% | — | Top 44% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.65×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +8.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.59×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 5.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 9.67%
- Shareholder yield
- 9.67%
- Share count change, 1 year
- -5.1%
- Share count change, 3-year CAGR
- -4.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 29, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +4.6%
- Average 2-day reaction, last 8
- -7.4%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $28.43
- Target vs current price
- +25.6%
- Analysts with a rating
- 15
- Share rating Buy or Strong Buy
- 73%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +5.6% | +6.5% | +5.4% | +5.2% | — |
| Apr 30, 2026 | +8.1% | -24.3% | -23.9% | -19.7% | -18.8% |
| Feb 24, 2026 | +0.0% | -6.3% | -12.4% | -21.3% | -42.2% |
| Oct 30, 2025 | +4.7% | -8.6% | -5.5% | +8.2% | +23.2% |
| Jul 30, 2025 | +2.5% | +1.7% | -6.7% | -7.3% | -6.1% |
| Apr 29, 2025 | +11.1% | -6.9% | -0.5% | -2.6% | -10.6% |
| Feb 26, 2025 | +6.1% | +1.6% | +4.6% | +7.8% | +0.2% |
| Oct 30, 2024 | +0.0% | -22.8% | -26.8% | -22.2% | +1.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $0.45 | $0.43 | +5.6% | $1.44B |
| Apr 30, 2026 | $0.40 | $0.37 | +8.1% | $1.35B |
| Feb 24, 2026 | $0.46 | $0.46 | +0.0% | $1.47B |
| Oct 30, 2025 | $0.45 | $0.43 | +4.7% | $1.44B |
| Jul 30, 2025 | $0.41 | $0.40 | +2.5% | $1.42B |
| Apr 29, 2025 | $0.40 | $0.36 | +11.1% | $1.33B |
| Feb 26, 2025 | $0.35 | $0.33 | +6.1% | $1.35B |
| Oct 30, 2024 | $0.31 | $0.31 | +0.0% | $1.28B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 17.0× | 25.9× | 5th | Top 7% |
| P/E (forward) | 12.0× | — | — | — |
| EV / EBITDA | 10.8× | — | — | Top 11% |
| EV / Sales | 0.78× | — | — | Top 6% |
| Free-cash-flow yield | 10.23% | — | — | Top 7% |
| Earnings yield | 5.87% | — | — | Top 7% |
P/E over the past five years
Range 15.8× – 77.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -16.9%
- Earnings per share growth (TTM)
- +6.4%
- Change in P/E multiple
- -26.6%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +3.5%
- 200-day average slope (20 days)
- -2.6%
- Distance from 50-day average
- -3.8%
- Distance from 200-day average
- -14.6%
- RSI (14)
- 39.3
- Relative volume
- 0.59×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 30.3%
- Volatility vs own 5-year history
- 23th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.48
- Correlation with S&P 500
- 0.18
- Current drawdown from 1-year high
- -38.1%
- Maximum drawdown, 3 years
- -46.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 22, 2026 | May 15, 2026 | -46.7% | 79 days | Not yet recovered |
| Aug 22, 2023 | Nov 18, 2024 | -38.7% | 313 days | 288 days (Jan 14, 2026) |
| Aug 15, 2022 | May 15, 2023 | -23.6% | 188 days | 67 days (Aug 21, 2023) |
| Jan 3, 2022 | Jan 27, 2022 | -22.5% | 17 days | 42 days (Mar 29, 2022) |
| Mar 15, 2021 | May 10, 2021 | -21.9% | 39 days | 22 days (Jun 10, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $3.39B
- P/E (TTM)
- 17.0
- EPS, diluted (TTM)
- $1.33
- Revenue (TTM)
- $5.69B
- 52-week range
- $18.01 – $36.80
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.44B | $3.94B | $4.30B | $5.00B | $5.65B |
| Gross profit | $779.6M | $866.9M | $981.2M | $1.01B | $1.02B |
| Operating income | $190.8M | $240.2M | $314.6M | $321.8M | $337.9M |
| Net income | $139.9M | $150.6M | $267.1M | $211.8M | $207.6M |
| EPS (diluted) | $0.77 | $0.83 | $1.48 | $1.23 | $1.27 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.28B | $1.35B | $1.33B | $1.42B | $1.44B | $1.47B | $1.35B | $1.44B |
| Net income | $53.9M | $60.1M | $46.7M | $50.5M | $51.8M | $58.5M | $45.3M | $53.9M |
| EPS (diluted) | $0.31 | $0.35 | $0.28 | $0.31 | $0.32 | $0.37 | $0.29 | $0.35 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $208.6M | $267.5M | $371.3M | $323.4M | $258.4M |
| Capital expenditure | -$25.6M | -$35.4M | -$41.9M | -$35.6M | -$41.3M |
| Free cash flow | $182.9M | $232.2M | $329.4M | $287.8M | $217.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$32,000 | $0 | -$250.3M | -$252.7M | -$310.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $193.8M
- Total assets
- $3.38B
- Total liabilities
- $2.12B
- Total debt
- $1.27B
- Net debt
- $1.07B
- Shareholders’ equity
- $1.26B
As of Jun 30, 2026 (filed Jul 29, 2026).
Short interest
- Shares sold short
- 12,098,760
- Days to cover
- 7.50
- Change vs previous report
- -4.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Feb 3, 2020
- 1-for-4